Loading clinical trials...
Loading clinical trials...
Magnesium Supplementation for Children With Drug Resistant Idiopathic Epilepsy: A Pilot Study
Effect of oral magnesium sulfate (Mg) supplementation will be studied. Children with drug resistant idiopathic epilepsy following up in Pediatric Neurology Clinic, Ain Shams University, will be randomized to either Mg add-on treatment group or anti-epileptic drugs AEDs alone. Serum magnesium, seizure control and Intelligent quotation (IQ) will be done at base line and after 6 months of treatment.
The Aim of this work was to study the effect of Magnesium as add on therapy on clinical seizure control in drug resistant idiopathic epilepsy and IQ.
Age
6 - 16 years
Sex
ALL
Healthy Volunteers
No
Children's Hospital, Faculty of Medicine, Ain Shams University
Cairo, Egypt
Start Date
September 1, 2016
Primary Completion Date
February 1, 2017
Completion Date
March 1, 2017
Last Updated
May 9, 2017
60
ACTUAL participants
Magnesium
DIETARY_SUPPLEMENT
Placebo - Concentrate
DRUG
Lead Sponsor
Ain Shams University
NCT03268824
NCT05019885
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions